𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neoadjuvant strategies for the treatment of locally advanced esophageal cancer

✍ Scribed by John R. Hyngstrom; Mitchell C. Posner

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
85 KB
Volume
101
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Patients with locally advanced esophageal carcinoma have consistently poor survival following surgery with associated high systemic and local‐regional failure rates. Neoadjuvant therapeutic strategies have been employed in an attempt to improve outcome with variable success. Randomized trials of either neoadjuvant chemotherapy or chemoradiotherapy have shown conflicting results regarding survival and local‐regional control. Future efforts should focus on identifying novel agents and targets to improve therapeutic efficacy. J. Surg. Oncol. 2010; 101:299–304. Β© 2010 Wiley‐Liss, Inc.

πŸ“œ SIMILAR VOLUMES

Neoadjuvant docetaxel treatment for loca
Neoadjuvant docetaxel treatment for locally advanced prostate cancer : A clinicopathologic study
✍ Cristina Magi-Galluzzi; Ming Zhou; Alwyn M. Reuther; Robert Dreicer; Eric A. Kle πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 250 KB

## Abstract ## BACKGROUND. The objective of the current study was to determine the histologic and molecular changes that occurred in patients with high‐risk, localized prostate cancer (PCa) after neoadjuvant docetaxel chemotherapy. ## METHODS. Patients who had locally advanced PCa (serum preoper

The toxicity and long-term efficacy of n
The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer
✍ Mingzhu Yin; Haiyu Zhang; Huiyan Li; Xia Li; Yunduo Liu; Xiuwei Chen; Ge Lou; Ka πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

## Abstract ## Background The use of neoadjuvant chemotherapy (NACT) for the treatment of locally advanced cervical cancer (LACC) remains controversial. In current clinical practice, platinum‐based chemotherapy is the major option for patients with LACC. However, serious adverse events have been r